OXY-SCORE and Volatile Anesthetics: A New Perspective of Oxidative Stress in EndoVascular Aneurysm Repair-A Randomized Clinical Trial.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Oct 2024
Historique:
received: 18 08 2024
revised: 29 09 2024
accepted: 29 09 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

An aortic aneurysm (AA) is a life-threatening condition. Oxidative stress may be a common pathway linking multiple mechanisms of an AA, including vascular inflammation and metalloproteinase activity. Endovascular aneurysm repair (EVAR) is the preferred surgical approach for AA treatment. During surgery, inflammation and ischemia-reperfusion injury occur, and reactive oxygen species (ROS) play a key role in their modulation. Increased perioperative oxidative stress is associated with higher postoperative complications. The use of volatile anesthetics during surgery has been shown to reduce oxidative stress. Individual biomarkers only partially reflect the oxidative status of the patients. A global indicator of oxidative stress (OXY-SCORE) has been validated in various pathologies. This study aimed to compare the effects of the main volatile anesthetics, sevoflurane and desflurane, on oxidative status during EVAR. Eighty consecutive patients undergoing EVAR were randomized into two groups: sevoflurane and desflurane. Plasma biomarkers of oxidative damage (protein carbonylation and malondialdehyde) and antioxidant defense (total thiols, glutathione, nitrates, superoxide dismutase, and catalase activity) were measured before surgery and 24 h after EVAR. The analysis of individual biomarkers showed no significant differences between the groups. However, the OXY-SCORE was positive in the desflurane group (indicating a shift towards antioxidants) and negative in the sevoflurane group (favoring oxidants) (

Identifiants

pubmed: 39409100
pii: ijms251910770
doi: 10.3390/ijms251910770
pii:
doi:

Substances chimiques

Anesthetics, Inhalation 0
Sevoflurane 38LVP0K73A
Biomarkers 0
Desflurane CRS35BZ94Q
Antioxidants 0
Reactive Oxygen Species 0
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : International Grant Anesthesia and Critical Care, Baxter S.L (2016)
ID : International Grant Anesthesia and Critical Care, Baxter S.L (2016)

Auteurs

Alba Burgos-Santamaría (A)

Department of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

Pilar Rodríguez-Rodríguez (P)

Department of Physiology, Faculty of Medicine, Autónoma University, 28029 Madrid, Spain.

Ana Arnalich-Montiel (A)

Department of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

Silvia M Arribas (SM)

Department of Physiology, Faculty of Medicine, Autónoma University, 28029 Madrid, Spain.

Carmen Fernández-Riveira (C)

Department of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

I María Barrio-Pérez (IM)

Department of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

Javier Río (J)

Department of Angiology and Vascular Surgery, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

José Manuel Ligero (JM)

Department of Angiology and Vascular Surgery, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

Begoña Quintana-Villamandos (B)

Department of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.
Department of Pharmacology and Toxicology, Faculty of Medicine, Complutense University, 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH